Study: ACE outperforms ARB in curbing albuminuria in type 2 diabetes

06/7/2011 | Doctor's Guide

A study presented at the annual meeting of The Endocrine Society found that the angiotensin-converting enzyme inhibitors fared better than angiotensin receptor blockers in reducing the risk of albuminuria in patients with type 2 diabetes. The findings suggest that ACE inhibitors could be more effective than ARBs in preventing renal disease in patients, experts said.

View Full Article in:

Doctor's Guide

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA